BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Which Carrier Do You Suggest? Vote - 2Shakira's 2026 'Las Mujeres Ya No Lloran' U.S. Tour: How to get tickets, prices, dates and more
- 3Iranian missile hit on Ne'ot Hovav factory leads to fear of chemical leakage
- 4Hitting the brakes: Hubble Space Telescope watches doomed comet reverse its spin
- 5Iranian strikes on Israel injure 11 and set chemical plant ablaze
- France will build a new aircraft carrier as it increases defense spending
- Gulf aluminum output tumbles on Iran war
- Extraordinary Snowboarding Objections All over the Planet
- Full Supreme Court to hear challenge to Judicial Selection Committee law
- Are IDF reservists properly armed during post-war operations?
- From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
- The ‘Stranger Things’ finale, explained: What happens to Vecna? And why was a key character’s fate left unknown?
- Turning into a Sharp Financial backer: Individual budget Wins
- Nigeria warns its citizens in South Africa to be cautious after march turns violent
